Results 1 - 10 of 17 : 1 2 Next
World's Scariest Stock: Dendreon
A volatile biotech with nowhere to go.
Biotech Investors' Dream Stocks
The best biotech stocks are within your reach.
Results IMPACT Volatility at Dendreon
Dendreon almost hits both a 52-week high and a 52-week low on the day it releases results.
3 Drugmakers With Multiple Shots on Goal
Well-stocked pipelines could kick these drugmakers into super-high gear.
Will Biopharma Acquisitions Never Cease?
Enough already! Give us poor, weary reporters a moment to rest.
Seattle Genetics Has What Others Want
Out-licensing its platform technology could mean big bucks.
Seattle Genetics Bulks Up Its Pipeline
Its biopharmaceutical clinical studies are firing on all cylinders.
The drugmaker raises some much-needed cash.
This cancer diagnostics business is worth big bucks.
Quick Take: Scoping Out the Investing Sluggers
Take a gander at these CAPS players that are swinging big bats.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK